PHUSE Archive
All materials from PHUSE Events can be found below. Use the filters to narrow your search.
Please reach out to communications@phuse.global if you require further assistance finding what you need.
Show/hide columns
| Event | Year | Region | City | Title | Author | Company | Co-author | Keywords | Links |
|---|---|---|---|---|---|---|---|---|---|
Connect | 2026 | APAC | Hyderabad | AS13: Leveraging Data Visualisation and R Shiny for Efficient Subgroup Analysis | Srinidhi Ramachandran | Eli Lilly | AS13; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS13.pdfPAP_AS13.pdf | |
Connect | 2026 | APAC | Hyderabad | RE04: Future-Focused Real-World Data Use Strategies: Resilience and Innovation at Chugai | Wataru Ohtsuka | Chugai Pharmaceutical | Nauta Yamanaka | RE04; Real-world Evidence & Data Visualisation | PRE_RE04.pdfPAP_RE04.pdf |
Connect | 2026 | APAC | Hyderabad | RE05: External Comparator Arms: Redefining Control in the Era of Real-World Data | Anshul Sinha | IQVIA | Vishal Goriya | RE05; Real-world Evidence & Data Visualisation; Best in Stream | PRE_RE05.pdfPAP_RE05.pdf |
Connect | 2026 | APAC | Hyderabad | AS15: Targeted Maximum Likelihood Estimation: A Unified Approach for Confounding and Selection Bias | Noel John | Catalyst Clinical Research – Catalyst Flex | Mahjoob O M | AS15; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS15.pdfPAP_AS15.pdf |
Connect | 2026 | APAC | Hyderabad | RE06: Early Detection of Adverse Events Associated with Antihypertensive Medications: A Real-World Evidence Study Using FAERS Data | Noel John | Catalyst Clinical Research – Catalyst Flex | Mahjoob O M | RE06; Real-world Evidence & Data Visualisation | PRE_RE06.pdfPAP_RE06.pdf |
Connect | 2026 | APAC | Hyderabad | RE07: An Open-Source Implementation of a Claims-Based Algorithm to Identify Pregnancy Episodes | Onkar Kshirsagar | GSK | Dhirishiya P | RE07; Real-world Evidence & Data Visualisation | PRE_RE07.pdfPAP_RE07.pdf |
Connect | 2026 | APAC | Hyderabad | AS17: Crafting a Recipe for Success: Aligning Target Product Profiles and Study Design To Ensure Statistical Significance Translates to Clinical Relevance | Soumitra Kar | Novo Nordisk | AS17; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS17.pdfPAP_AS17.pdf | |
Connect | 2026 | APAC | Hyderabad | RE08: From Static to Interactive: A Comparative Evaluation of ggplot2 and Plotly in Clinical Data Visualisation | Mugdha Joshi | Eli Lilly | RE08; Real-world Evidence & Data Visualisation | PRE_RE08.pdfPAP_RE08.pdf | |
Connect | 2026 | APAC | Hyderabad | RE09: Reimagining Clinical Data Exploration: Animated Data Visualisations for Interactive Clinical Trial Storytelling | Tony Mathew | Pfizer | RE09; Real-world Evidence & Data Visualisation | PRE_RE09.pdfPAP_RE09.pdf | |
Connect | 2026 | APAC | Hyderabad | AS18: Illustrating Treatment Switching Using a Rank-Preserving Structural Failure Time Model in an Oncology Study | Swarupa Changan | eClinical Solutions | AS18; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS18.pdfPAP_AS18.pdf | |
Connect | 2026 | APAC | Hyderabad | RE10: Optimizing Workflow in Pharma: Innovative Dashboard Creation | Dikshit A | Novo Nordisk | RE10; Real-world Evidence & Data Visualisation | PRE_RE10.pdfPAP_RE10.pdf | |
Connect | 2026 | APAC | Hyderabad | RE11: Building a Trustworthy RWD Analytic Platform: Key Considerations and Strategies | William Kuan | SAS | Ashwini Reddy | RE11; Real-world Evidence & Data Visualisation; Best in Connect | PRE_RE11.pdfPAP_RE11.pdf |
Connect | 2026 | APAC | Hyderabad | AS19: Time-to-Event Analysis in Pain Management: A Case Study of the Double Stopwatch Method and ADaM Dataset Development in Relation to Rescue Medication | Abhishek Paul | Sanofi | Arnode Mukherjee | AS19; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS19.pdfPAP_AS19.pdf |
Connect | 2026 | APAC | Hyderabad | RE12: AI-Powered Precision: Transforming Limb Salvage Decisions in Diabetic Foot Syndrome | Kumar Sambhav | Saama | RE12; Real-world Evidence & Data Visualisation | PRE_RE12.pdfPAP_RE12.pdf | |
Connect | 2026 | APAC | Hyderabad | RE13: Integrating Real-World Evidence (RWE) and Digital Health Technologies (DHTs) with AI for Enhanced Patient Outcomes (RE) | Sasikala Munirathinam Ponneeswaran | Hexaware Technologies | Varun Sethuraman | RE13; Real-world Evidence & Data Visualisation | PRE_RE13.pdfPAP_RE13.pdf |
Connect | 2026 | APAC | Hyderabad | AS20: Beyond Toxicity: Accelerating Dose Finding with Pharmacokinetic-Driven Bayesian Design PKBOIN-12 | Anetta Mary Xavier | eClinical Solutions | AS20; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS20.pdfPAP_AS20.pdf | |
Connect | 2026 | APAC | Hyderabad | RE14: Leveraging Large Language Models for Missing Data Imputation and Interpretation of Real-World Evidence Outputs | Spencer Langerman | Flatiron Health | Rahul Manohar Somavanshi | RE14; Real-world Evidence & Data Visualisation | PRE_RE14.pdfPAP_RE14.pdf |
Connect | 2026 | APAC | Hyderabad | RE15: Leveraging Real-World Evidence (RWE) in Clinical Trial Design: Statistical Challenges and Opportunities | Muhammed Farzan K | Pfizer | RE15; Real-world Evidence & Data Visualisation | PRE_RE15.pdfPAP_RE15.pdf | |
Connect | 2026 | APAC | Hyderabad | AS22: From Data to Digital Phenotypes: Modelling High-Dimensional PROs and Actigraphy Data in Decentralized Psychiatric Trials | Sakshi Kaushik | ICON | AS22; Analytics & Statistics & Analytical Risk-Based Monitoring | PRE_AS22.pdfPAP_AS22.pdf | |
Connect | 2026 | APAC | Hyderabad | RE16: The Expanding Role of Real-World Evidence (RWE) in Supporting Regulatory Submissions | Nikhil A | Norstella | Setu Sagar | RE16; Real-world Evidence & Data Visualisation | PRE_RE16.pdfPAP_RE16.pdf |